August 2026 Br J Cardiol 2026;33(suppl 2):S3–S23 doi:10.5837/bjc.2026.s02
Beverley Bostock, Jaimini Cegla, Emily Turner, Waqas Tahir, Alison Pottle, Derek Connolly, Michael H Cummings, Dev BN Datta, Paul F Downie, Elizabeth Hughes, Jim Moore, Kausik K Ray, on behalf of the BEACON Steering Committee
The BEACON Steering Committee The Bringing Education and Awareness to Cholesterol Optimisation Needs (BEACON) steering committee comprises a multidisciplinary group of healthcare professionals that aims to provide education and advice regarding lipid management, including the streamlining of associated pathways, in clinical practice across the UK. The group is committed to the development of educational resources that will support care providers and help to reshape and align current processes, improve knowledge and enable greater understanding of the rapidly changing lipid-lowering treatment pathway as new therapies become available.
May 2023 Br J Cardiol 2023;30(suppl 2):S3 doi:10.5837/bjc.2023.s05
Derek Connolly
There is substantial evidence that a diet rich in fish results in lower levels of atherosclerosis. This has led to the hypothesis that fish oils, which are known to reduce triglyceride levels – an independent risk for cardiovascular events – might also reduce the level of cardiovascular disease possibly by lowering triglycerides. The open-label Japan EPA Lipid Intervention Study (JELIS) used a highly purified, fish oil extract containing only eicospentaenoic acid (EPA) and showed a reduction in cardiovascular events.3 This led to the large, randomised, double-blind, placebo-controlled, multinational trial called the Reduction of Cardiovas
February 2011 Br J Cardiol 2011;18:37-45
Alexandra MacLean, James M McKenney, Russell Scott, Eliot Brinton, Harold E Bays, Yale B Mitchel, John F Paolini, Hilde Giezek, Kristel Vandormael, Rae Ann Ruck, Kendra Gibson, Christine McCrary Sisk, Darbie L Maccubbin
An extended version of this paper is available in the downloadable PDFs (see right hand column) to registered users. Registration to the website is free of charge. Introduction Patients with type 2 diabetes mellitus (T2DM) have a two- to four-fold increased risk for cardiovascular disease (CVD) compared with individuals without T2DM.1 A dyslipidaemia pattern of increased levels of triglyceride (TG)-rich particles, and TG enrichment of high- and low-density lipoprotein (HDL and LDL) is common in patients with T2DM, affecting nearly all lipid and lipoprotein variables.2 As a result, dyslipidaemia in patients with T2DM is characterised by el
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits